Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Aclaris Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 107 | 98 | −9 |
| Shares | 58.5M | 54.4M | −4.04M (−6.9%) |
| Value | $61.4M | $67.5M | +$6.04M (+9.8%) |
New holders (18)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AQR Capital Management LLC | 612,205 | $759.1K | 0.00% |
| Palo Alto Investors LP | 569,832 | $706.6K | 0.08% |
| Acuitas Investments, LLC | 461,663 | $572.5K | 0.29% |
| Connor, Clark & Lunn Investment Management Ltd. | 100,773 | $125.0K | 0.00% |
| Marquette Asset Management, LLC | 83,979 | $104.1K | 0.02% |
| Deuterium Capital Management, LLC | 79,993 | $99.2K | 0.18% |
| BBR Partners, LLC | 60,000 | $74.4K | 0.01% |
| Verition Fund Management LLC | 53,835 | $66.8K | 0.00% |
| HSBC Holdings PLC | 46,358 | $57.5K | 0.00% |
| Harbor Capital Advisors, Inc. | 30,984 | $38.0K | 0.00% |
| Simplex Trading, LLC | 28,064 | $34.0K | 0.00% |
| Two Sigma Securities, LLC | 16,114 | $20.0K | 0.00% |
| Algert Global LLC | 15,801 | $19.6K | 0.00% |
| FNY Investment Advisers, LLC | 10,000 | $12.0K | 0.01% |
| Cornerstone Planning Group LLC | 580 | $789 | 0.00% |
| Advisor Group Holdings, Inc. | 124 | $154 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 14 | $17 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 31,552 | – | – |
Sold out (27)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.